Clinical trials
Phase 1 Breast Carcinoma In Situ trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| Jonsson Comprehensive Cancer Center | 2 |
| Mayo Clinic | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Katherine D. Crew | 1 |
| Mark Dewhirst | 1 |
| NYU Langone Health | 1 |
| Providence Health & Services | 1 |
| Roswell Park Cancer Institute | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Carcinoma In Situ | 19 |
| Breast Neoplasms | 12 |
| Carcinoma, Intraductal, Noninfiltrating | 11 |
| Triple Negative Breast Neoplasms | 2 |
| Carcinoma, Ductal, Breast | 1 |
| Carcinoma, Lobular | 1 |
| Head and Neck Neoplasms | 1 |
| Hypopharyngeal Neoplasms | 1 |
| Inflammatory Breast Neoplasms | 1 |
| Laryngeal Neoplasms | 1 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.